Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples